Sort
82,697 grants matching “vaccine development”
DEVELOPMENT OF AN ADHESION BASED VACCINE.
$1,119,348University Of Georgia Research Foundation, Inc. · · FY2009 · Defense Threat Reduction Agency
Core B - MappBiopharmaceutical, Inc.
$1,119,154Larry Zeitlin · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2021 · AI
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
$1,119,079Vilasack Thammavongsa · Immunartes Llc · N01 · FY2022 · AI
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo
$1,119,073Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Examination of Enteric Pathogens with Multi-Omic Approaches
$1,118,839David A Rasko · University Of Maryland Baltimore · U19 · FY2016 · AI
Application of Flow Cytometry to Cell Biology
$1,118,661Susan Sharrow · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoea
$1,118,405Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · AI
National Resource for Automated Molecular Microscopy
$1,118,166Bridget Olivia Carragher · New York Structural Biology Center · P41 · FY2015 · GM
Immunobiology and immunotherapy of leukemia
$1,117,867Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Characterization and improvement of graft versus leukemia effects
$1,117,867Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Lymphocyte Dynamics
$1,117,836William Paul · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Broad Spectrum Neutralizing Human Abs to SARS and Related Coronaviruses
$1,117,743Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2011 · AI
Preclinical Evaluation of Novel Ad/MVA and Ad/Protein HIV-1 Vaccines
$1,117,704Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2015 · AI
Interaction of HIV envelope with cell surface receptors
$1,117,501Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever
$1,117,358Thomas William Geisbert · University Of Texas Med Br Galveston · R01 · FY2020 · AI
NIAID Preclinical Development Support - Development of clade C Vaccine
$1,117,336Nancy Lin · Advanced Bioscience Laboratories, Inc. · N01 · FY2014 · AI
Kaiser Washington Vaccine and Treatment Evaluation Unit
$1,117,166Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2021 · AI
Preventive Vaccines for HIV
$1,116,963Genoveffa Franchini · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Pediatric AIDS Clinical Trials Group
$1,116,567St. Jude Children'S Research Hospital · U01 · FY2003 · AI
Development Of Vaccines For Genital Herpes Simplex Infection
$1,116,436Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Herpesvirus Pathogenesis and Vaccine Development
$1,116,434Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
NIDA Clinical Trials Network: Greater New York Node
$1,116,411John P Rotrosen · New York University School Of Medicine · UG1 · FY2015 · DA
IND-enabling Preclinical Studies on Anti-Tau AD Vaccine for Phase 1 Trial
$1,116,260Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2019 · AG
Malaria Drug Resistance and Disease Virulence
$1,115,998Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Advanced Development of a Combined Shigella-ETEC Vaccine
$1,115,547Eileen M. Barry · University Of Maryland Baltimore · R01 · FY2024 · AI